Tag: acid reflux
-
Acid reflux drugs do not cause cancer after all, study finds
New Study Dismisses Long-Standing Cancer Link to Acid Reflux Drugs For four decades, scientists and clinicians have periodically warned that proton pump inhibitors (PPIs) used to treat acid reflux could be tied to cancer. Omeprazole, lansoprazole and other PPIs are among the most commonly prescribed medicines in Britain, with millions relying on them for relief…
-
New Study Douses Link Between Acid Reflux Drugs and Cancer
Long-Standing Concerns About Acid Reflux Meds For decades, proton pump inhibitors (PPIs) like omeprazole and lansoprazole have been the go-to treatment for heartburn, acid reflux, and ulcers. Yet a persistent fear lingered in public discourse: could these widely prescribed drugs raise cancer risk? A new study aims to settle the debate, providing reassurance to millions…
-
Acid reflux drugs do not cause cancer, study finds: Long‑standing link debunked
New findings ease long‑standing fears about acid reflux medications For decades, concerns about a possible link between proton pump inhibitors (PPIs) and cancer have persisted. These widely used drugs, including omeprazole, esomeprazole, pantoprazole, and lansoprazole, are frontline treatments for gastroesophageal reflux disease (GERD), ulcers, and other digestive conditions. A major new study has found no…
-
NHS Urges Caution: Reassessing Eight-Week Use of Omeprazole and Lansoprazole
What has the NHS said about eight-week PPI use? Health services in the United Kingdom have sounded a clear warning to people who rely on the proton pump inhibitors (PPIs) omeprazole and lansoprazole for digestive issues. The NHS advises patients and prescribers to reassess the need for continued therapy after around eight weeks. While these…
-
NHS Issues Eight-Week Warning for Omeprazole Users
What the NHS warning means for omeprazole and lansoprazole users Many people rely on proton pump inhibitors (PPIs) such as omeprazole and lansoprazole to manage common digestive problems, including gastroesophageal reflux disease (GERD), heartburn, and gastritis. Recently, the NHS issued guidance prompting patients to review their use of these medicines after a typical course of…
-
NHS Urges Review of Omeprazole and Lansoprazole Use After Eight-Week Warning
What the NHS eight-week warning means for omeprazole and lansoprazole users Many people turn to proton pump inhibitors (PPIs) like omeprazole and lansoprazole to relieve heartburn, acid reflux, and other gastric issues. Recently, the NHS issued a caution that patients should regularly review their usage and consider tapering or stopping these medications after about eight…
-
NHS Alerts on Long-Term Lansoprazole Use: What Patients Need to Know
What the NHS alert means for patients The National Health Service (NHS) has issued a warning for people who have been taking lansoprazole for three months or more. Lansoprazole is a commonly prescribed proton pump inhibitor (PPI) used to treat conditions caused by excess stomach acid, such as gastroesophageal reflux disease (GERD), ulcers, and heartburn.…
-
NHS Alerts on Long-Term Lansoprazole Use: What You Need to Know
What the NHS alert means for you The NHS has issued a public warning regarding the long-term use of lansoprazole, a widely prescribed proton pump inhibitor (PPI) used to treat conditions caused by excess stomach acid, such as GERD and ulcers. The alert specifically targets individuals who have been taking lansoprazole for three months or…
-
The Hidden Dangers of Late Dinners: From Acid Reflux to Heart Disease
The Hidden Health Toll of Late Dinners Eating dinner late into the night isn’t just a minor dietary habit; it can quietly undermine long-term health. From triggering acid reflux to increasing cardiovascular risk, late meals disrupt several body systems that rely on orderly rhythms. For many people, late dining is a result of busy work…